Risk of Chronic Kidney Disease in Non-Obese Individuals with Clustering of Metabolic Factors: A Longitudinal Study

被引:20
|
作者
Nishikawa, Kunihito [1 ,2 ]
Takahashi, Ken [2 ]
Okutani, Toshio [1 ]
Yamada, Ryoji [1 ]
Kinaga, Tsuyoshi [1 ]
Matsumoto, Masato [1 ]
Yamamoto, Masayuki [1 ]
机构
[1] Shinko Hosp, Ctr Med Check Up, Shinkokai, Japan
[2] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Environm Epidemiol, Kitakyushu, Fukuoka, Japan
关键词
chronic kidney disease; metabolic syndrome; obesity; proteinuria; renal dysfunction; INTERNATIONAL-DIABETES-FEDERATION; CHOLESTEROL EDUCATION-PROGRAM; ISCHEMIC-HEART-DISEASE; IDF CRITERIA; DEFINITION; OBESITY; COMPONENTS; POPULATION; PREDICT; IMPACT;
D O I
10.2169/internalmedicine.54.3092
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective The impact of the clustering of metabolic factors on chronic kidney disease (CKD) in non-obese individuals remains unclear. Methods We conducted a follow-up study of 23,894 Japanese adults (age, 18-69 years) who continuously received annual health examinations between 2000 and 2011. Obesity, high blood pressure, high triglycerides, low high-density lipoprotein (HDL) cholesterol and high fasting blood sugar were defined as metabolic factors, and CKD was defined as renal dysfunction (estimated glomerular filtration rate: <60 mL/min/1.73 m(2)) or proteinuria (dipstick test: >= 1+). The association between the clustering of metabolic factors and CKD was assessed based on the presence or absence of obesity using a Cox proportional hazard model. Results Of 2,867 subjects with >= 3 metabolic factors, 650 (22.7%) were non-obese. These individuals were older and had higher metabolic risks than their obese counterparts at baseline. Among the entire cohort of 23,894 subjects, 1,764 developed renal dysfunction and 904 developed proteinuria during an average follow-up period of 7.8 years. The cumulative incidence of renal dysfunction was higher (22.1% vs. 16.1%), whereas that of proteinuria was lower (10.5% vs. 14.4%), among the non-obese subjects with >= 3 metabolic factors than the obese subjects with >= 3 metabolic factors after 11 years. The adjusted relative risk (RR) (95% confidence interval) of renal dysfunction was 1.54 (1.34-1.77) and 1.67 (1.35-2.07) for the obese and non-obese subjects with >= 3 metabolic factors, respectively. Conclusion Non-obese subjects with >= 3 metabolic factors, who are missed based on the essential criterion of obesity for metabolic syndrome, may have an equal or slightly higher risk of renal dysfunction than obese subjects with >= 3 metabolic factors.
引用
收藏
页码:375 / 382
页数:8
相关论文
共 50 条
  • [1] Lower physical activity is a risk factor for a clustering of metabolic risk factors in non-obese and obese Japanese subjects: The Takahata study
    Kaino, Wataru
    Daimon, Makoto
    Sasaki, Satoshi
    Karasawa, Shigeru
    Takase, Kaoru
    Tada, Kyouko
    Wada, Kiriko
    Kameda, Wataru
    Susa, Shinji
    Oizumi, Toshihide
    Fukao, Akira
    Kubota, Isao
    Kayama, Takamasa
    Kato, Takeo
    ENDOCRINE JOURNAL, 2013, 60 (05) : 617 - 628
  • [2] Risk for Non-obese Japanese Workers to Develop Metabolic Syndrome
    Inada, Fumi
    Moriguchi, Jiro
    Okuda, Tomoko
    Ide, Yoko
    Ejima, Kiriko
    Sakuragi, Sonoko
    Takeda, Kazuo
    Ohashi, Fumiko
    Ikeda, Masayuki
    INDUSTRIAL HEALTH, 2010, 48 (04) : 487 - 494
  • [3] Prevalence and Risk Factors of Non-Alcoholic Fatty Liver Disease (NAFLD) in Non-Obese Patients with Schizophrenia: A Retrospective Study
    Yi, Wenying
    Wu, Haibo
    Fu, Weibin
    Feng, Huimei
    Huang, Jie
    Li, Haijing
    Song, Zhen
    Chen, Yuwei
    Zheng, Yingjun
    She, Shenglin
    DIABETES METABOLIC SYNDROME AND OBESITY, 2024, 17 : 841 - 849
  • [4] Non-obese non-alcoholic fatty liver disease and the risk of chronic kidney disease: a systematic review and meta-analysis
    You, Yixian
    Pei, Xiong
    Jiang, Wei
    Zeng, Qingmin
    Bai, Lang
    Zhou, Taoyou
    Lv, Xiaoju
    Tang, Hong
    Wu, Dongbo
    PEERJ, 2024, 12
  • [5] Prevalence, risk factors and metabolic profile of the non-obese and obese non-alcoholic fatty liver disease in a rural community of South Asia
    Rahman, M. Masudur
    Kibria, Md Golam
    Begum, Hasina
    Haque, Mazhar
    Sultana, Nigar
    Akhter, Mahfuza
    Rowshon, A. H. M.
    Ahmed, Faruqe
    Hasan, Mahmud
    BMJ OPEN GASTROENTEROLOGY, 2020, 7 (01):
  • [6] Metabolic status indicators and influencing factors in non-obese, non-centrally obese nonalcoholic fatty liver disease
    Huang, Zhipeng
    Wei, Donghong
    Yu, Xueping
    Huang, Zicheng
    Lin, Yijie
    Lin, Wenji
    Su, Zhijun
    Jiang, Jianjia
    MEDICINE, 2023, 102 (06)
  • [7] Clustering of metabolic abnormalities in obese individuals: the role of genetic factors
    Ukkola, O
    Bouchaud, C
    ANNALS OF MEDICINE, 2001, 33 (02) : 79 - 90
  • [8] A Challenging Interaction of Chronic Kidney Disease With Other Metabolic Disorders Paradoxes in Cardiometabolic Risk Factors
    Panahi, Mohammad Hossein
    Hadaegh, Farzad
    Yavari, Parvin
    Kazempour-Ardebili, Sara
    Mehrabi, Yadollah
    Azizi, Fereidoun
    Khalili, Davood
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2016, 10 (05) : 274 - 281
  • [9] Weight Change across Adulthood in Relation to Non-Alcoholic Fatty Liver Disease among Non-Obese Individuals
    Ding, Yuqing
    Xu, Xin
    Tian, Ting
    Yu, Chengxiao
    Ge, Xinyuan
    Gao, Jiaxin
    Lu, Jing
    Ge, Zijun
    Jiang, Tao
    Jiang, Yue
    Ma, Hongxia
    Song, Ci
    Hu, Zhibin
    NUTRIENTS, 2022, 14 (10)
  • [10] Metabolic syndrome and chronic kidney disease as risk factors of osteoporosis
    Shin, Jung-ho
    Kim, Su Hyun
    Yu, Suk-Hee
    CLINICAL NEPHROLOGY, 2014, 81 (01) : 1 - 8